Circulating fgf21 and gdf15 as biomarkers for screening, diagnosis, and severity assessment of primary mitochondrial disorders in children

HIGHLIGHTS

  • who: Yi Guo from the Department of Neurology, Children`s Hospital of Chongqing Medical University, Chongqing, China, National Clinical have published the research: Circulating FGF21 and GDF15 as Biomarkers for Screening, Diagnosis, and Severity Assessment of Primary Mitochondrial Disorders in Children, in the Journal: (JOURNAL)
  • what: The authors investigated FGF21 and GDF15 levels in a cohort of children and evaluated the significance of FGF21 and GDF15 levels in the diagnosis, severity assessment, and correlation of phenotypes and genotypes of PMDs. This study was approved by the ethics committee of the Children`s Hospital affiliated to . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?